Drug profile · INN
chloroprocaine hydrochloride
CHLOROPROCAINE HYDROCHLORIDE
chloroprocaine hydrochloride (CHLOROPROCAINE HYDROCHLORIDE) is a sodium channel alpha subunit blocker. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — chloroprocaine hydrochloride
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
chloroprocaine hydrochloride (CHLOROPROCAINE HYDROCHLORIDE) is a sodium channel alpha subunit blocker. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Sodium channel alpha subunit blocker
Primary target: Sodium channel alpha subunit
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is chloroprocaine hydrochloride?
chloroprocaine hydrochloride (CHLOROPROCAINE HYDROCHLORIDE) is a sodium channel alpha subunit blocker. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for chloroprocaine hydrochloride?
CHLOROPROCAINE HYDROCHLORIDE is a marketed brand name for chloroprocaine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of chloroprocaine hydrochloride?
chloroprocaine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.